Race to control silent liver disease hits pause
Disease control
Terminated
This study is testing whether a drug called Aramchol can reduce liver scarring and inflammation in people with NASH, a serious fatty liver disease. The trial involves about 150 adults with confirmed NASH and some liver scarring. It compares Aramchol against a placebo to see if it…
Phase: PHASE3 • Sponsor: Galmed Research and Development, Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC